A routine shingles shot may offer powerful defense against dementia
A study of over 280,000 older adults in Wales found shingles vaccination cut dementia risk by 20% and halved dementia-related deaths among those with the disease.
- A routine shingles shot containing a live-attenuated virus may offer protection against dementia, lowering the likelihood of a dementia diagnosis by 20% compared to those who did not receive it.
- Individuals with dementia who received the shingles shot were significantly less likely to die from dementia in the next nine years, suggesting the disease progressed more slowly in the vaccinated group.
- The protective effect of the shingles vaccine against dementia appeared to be much stronger in women than in men, though the reason is unclear.
20 Articles
20 Articles
A routine shingles shot may offer powerful defense against dementia
A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect.
Shingles vaccine linked to 20% lower risk of dementia in older adults
A new study suggests the shingles vaccine could reduce dementia risk and may even slow progression in those already diagnosed, offering hope for millions A recent study finds that older adults who receive the shingles vaccine have a lower risk of developing dementia and may experience slower progression if already diagnosed. This research could provide a simple, widely available way to help protect brain health and improve outcomes for millions …
Coverage Details
Bias Distribution
- 44% of the sources lean Left, 44% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium














